Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Membranoproliferative glomerulonephritis--a new look at an old entity.

Sethi S, Fervenza FC.

N Engl J Med. 2012 Mar 22;366(12):1119-31. doi: 10.1056/NEJMra1108178. Review. No abstract available.

PMID:
22435371
2.

New aspects of membranoproliferative glomerulonephritis.

Manenti L, Vaglio A, Buzio C.

N Engl J Med. 2012 Jul 5;367(1):86; author reply 86-7. doi: 10.1056/NEJMc1205019#SA1. No abstract available.

PMID:
22762333
3.

Redefining C3 glomerulopathy: 'C3 only' is a bridge too far.

Larsen CP, Walker PD.

Kidney Int. 2013 Feb;83(2):331-2. doi: 10.1038/ki.2012.385. No abstract available.

PMID:
23364589
4.

Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.

Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.

Mol Immunol. 2009 Sep;46(14):2801-7. doi: 10.1016/j.molimm.2009.05.018. Epub 2009 Jul 28. Review.

PMID:
19640589
5.

The authors reply:.

Servais A, Noel LH, Lesavre P, Frémeaux-Bacchi V.

Kidney Int. 2013 Feb;83(2):332-3. doi: 10.1038/ki.2012.381. No abstract available.

PMID:
23364592
6.

Dense deposit disease: new insights.

Walker PD.

Curr Opin Nephrol Hypertens. 2007 May;16(3):204-12. Review.

PMID:
17420663
7.

Pathogenic mechanisms in membranoproliferative glomerulonephritis.

Smith KD, Alpers CE.

Curr Opin Nephrol Hypertens. 2005 Jul;14(4):396-403. Review.

PMID:
15931011
8.

The spectrum of complement alternative pathway-mediated diseases.

Holers VM.

Immunol Rev. 2008 Jun;223:300-16. doi: 10.1111/j.1600-065X.2008.00641.x. Review.

PMID:
18613844
9.

Update on membranoproliferative GN.

Masani N, Jhaveri KD, Fishbane S.

Clin J Am Soc Nephrol. 2014 Mar;9(3):600-8. doi: 10.2215/CJN.06410613. Epub 2014 Jan 9. Review.

10.

A mechanism for the development of subepithelial deposits in a patient with type III membranoproliferative glomerulonephritis.

Fujigaki Y, Ohashi N, Yonemura K, Fujimoto T, Fukasawa H, Togawa A, Suzuki H, Yasuda H, Yamamoto T, Hishida A.

Nephrology (Carlton). 2003 Dec;8(6):280-4.

PMID:
15012698
11.

Early recurrence of type 1 membranoproliferative glomerulonephritis following cadaveric renal transplantation.

Dwyer K, Hill P, Murphy B.

Aust N Z J Med. 2000 Feb;30(1):103-4. No abstract available.

PMID:
10800897
12.

Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation.

Leroy V, Fremeaux-Bacchi V, Peuchmaur M, Baudouin V, Deschênes G, Macher MA, Loirat C.

Pediatr Nephrol. 2011 Mar;26(3):419-24. doi: 10.1007/s00467-010-1734-4. Epub 2010 Dec 25.

PMID:
21188423
13.

Prolonged hypocomplementaemia after post-streptococcal glomerulonephritis.

Butani L.

Nephrol Dial Transplant. 2001 Apr;16(4):869. No abstract available.

14.

Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.

Sethi S, Fervenza FC.

Semin Nephrol. 2011 Jul;31(4):341-8. doi: 10.1016/j.semnephrol.2011.06.005. Review.

PMID:
21839367
15.

Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon.

Levy Y, George J, Yona E, Shoenfeld Y.

Immunol Res. 1998 Aug;18(1):55-60. Review.

PMID:
9724849
16.

Membranoproliferative glomerulonephritis in a girl and her mother.

Motoyama O, Sakai K, Ohashi Y, Mizuiri S, Hatori T, Iitaka K, Koitabashi Y.

Clin Exp Nephrol. 2009 Feb;13(1):77-80. doi: 10.1007/s10157-008-0070-5. Epub 2008 Jul 19.

PMID:
18641916
17.

Membranoproliferative glomerulonephritis in a patient with congenital deficiency of the third component of complement: effect of treatment with plasma.

Roord JJ, van Diemen-van Steenvoorde RA, Schuurman HJ, Rijkers GT, Zegers BJ, Gmelig Meyling FH, Stoop JW.

Am J Kidney Dis. 1989 May;13(5):413-7.

PMID:
2719026
18.

Lipodystrophy in MCGN type II: the clue to links between the adipocyte and the complement system.

Mathieson PW, Peters DK.

Nephrol Dial Transplant. 1997 Sep;12(9):1804-6. Review. No abstract available.

19.

Complement in glomerular injury.

Berger SP, Daha MR.

Semin Immunopathol. 2007 Nov;29(4):375-84. Epub 2007 Sep 28. Review.

20.

[Clinical study of complement system abnormality and glomerulonephritis].

Ohi H, Kojima H, Seki M.

Nihon Rinsho. 1988 Sep;46(9):2030-4. Japanese. No abstract available.

PMID:
3241392
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk